Empagliflozin 25 Mg Tablets (Glimpazin-25) - 100 Tablets

Glimpazin-25 (Empagliflozin 25 mg Tablets):

Product Information- Brand Name: Glimpazin-25
- Active Ingredient: Empagliflozin
- Strength: 25 mg
- Form: Tablets

Therapeutic Class

- Antidiabetic agent
- SGLT2 inhibitor

Indications

- Treatment of type 2 diabetes mellitus
- Improves glycemic control
- Reduces risk of cardiovascular events
- Adjunct to diet and exercise

Mechanism of Action

- Inhibits sodium-glucose cotransporter 2 (SGLT2)
- Reduces glucose reabsorption in kidneys
- Increases glucose excretion in urine

Benefits

- Effective glycemic control
- Reduced risk of cardiovascular events
- Convenient once-daily dosing
- Weight loss potential
- Improved blood pressure control

Side Effects

- Common:
    - Urinary tract infections
    - Increased urination
    - Thirst
    - Headache
    - Hypoglycemia (low blood sugar)
- Less common:
    - Allergic reactions
    - Increased risk of genital mycotic infections
    - Increased risk of acute kidney injury

Contraindications

- Hypersensitivity to empagliflozin
- Severe kidney impairment (eGFR <30 mL/min/1.73 m²)
- End-stage renal disease (ESRD)
- Dialysis
- Pregnancy and lactation (caution advised)

Precautions

- Monitor blood sugar, kidney function, and liver enzymes regularly
- Inform doctor about concomitant medications
- Caution in patients with:
    - Renal or hepatic impairment
    - History of pancreatitis
    - History of hypersensitivity reactions